Trial Profile
Study of ranibizumab for the treatment of retinal vein occlusion
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Aug 2016
Price :
$35
*
At a glance
- Drugs Ranibizumab (Primary)
- Indications Retinal oedema; Retinal vein occlusion
- Focus Therapeutic Use
- 17 Aug 2016 New trial record